To explore the clinical significance of CD151 expression in NSCLC, CD151 expression levels were first analysed via immunohistochemical staining of tissue biopsies from 155 NSCLC patients in the NUH cohort (Figure 1A). The gene discussed is CD151; the disease is non-small cell lung carcinoma.